Global (United States, European Union and China) Influenza Vaccine Market Research Report 2019-2025
SKU ID :QYR-14390382 | Published Date: 29-Aug-2019 | No. of pages: 128Description
TOC
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Fluzone/Vaxigrip
1.3.3 FluMist
1.3.4 Fluarix and Flulaval
1.3.5 Anflu
1.3.6 Fluvax/Afluria
1.3.7 Flucelvax and Fluvirin
1.4 Market Segment by Application
1.4.1 Global Influenza Vaccine Market Share by Application (2019-2025)
1.4.2 Adults
1.4.3 Pediatrics
1.4.4 Senior Citizens
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Vaccine Market Size
2.1.1 Global Influenza Vaccine Revenue 2014-2025
2.1.2 Global Influenza Vaccine Sales 2014-2025
2.2 Influenza Vaccine Growth Rate by Regions
2.2.1 Global Influenza Vaccine Sales by Regions 2014-2019
2.2.2 Global Influenza Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Influenza Vaccine Sales by Manufacturers
3.1.1 Influenza Vaccine Sales by Manufacturers 2014-2019
3.1.2 Influenza Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Influenza Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Influenza Vaccine Price by Manufacturers
3.4 Key Manufacturers Influenza Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Influenza Vaccine Market
3.6 Key Manufacturers Influenza Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Fluzone/Vaxigrip Sales and Revenue (2014-2019)
4.1.2 FluMist Sales and Revenue (2014-2019)
4.1.3 Fluarix and Flulaval Sales and Revenue (2014-2019)
4.1.4 Anflu Sales and Revenue (2014-2019)
4.1.5 Fluvax/Afluria Sales and Revenue (2014-2019)
4.1.6 Flucelvax and Fluvirin Sales and Revenue (2014-2019)
4.2 Global Influenza Vaccine Sales Market Share by Type
4.3 Global Influenza Vaccine Revenue Market Share by Type
4.4 Influenza Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Influenza Vaccine Sales by Application
6 United States
6.1 United States Influenza Vaccine Breakdown Data by Company
6.2 United States Influenza Vaccine Breakdown Data by Type
6.3 United States Influenza Vaccine Breakdown Data by Application
7 European Union
7.1 European Union Influenza Vaccine Breakdown Data by Company
7.2 European Union Influenza Vaccine Breakdown Data by Type
7.3 European Union Influenza Vaccine Breakdown Data by Application
8 China
8.1 China Influenza Vaccine Breakdown Data by Company
8.2 China Influenza Vaccine Breakdown Data by Type
8.3 China Influenza Vaccine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Influenza Vaccine Breakdown Data by Company
9.2 Rest of World Influenza Vaccine Breakdown Data by Type
9.3 Rest of World Influenza Vaccine Breakdown Data by Application
9.4 Rest of World Influenza Vaccine Breakdown Data by Countries
9.4.1 Rest of World Influenza Vaccine Sales by Countries
9.4.2 Rest of World Influenza Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Influenza Vaccine
10.1.4 Influenza Vaccine Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 CSL
10.2.1 CSL Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Influenza Vaccine
10.2.4 Influenza Vaccine Product Introduction
10.2.5 CSL Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Influenza Vaccine
10.3.4 Influenza Vaccine Product Introduction
10.3.5 GlaxoSmithKline Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Influenza Vaccine
10.4.4 Influenza Vaccine Product Introduction
10.4.5 Sanofi Recent Development
10.5 Altimmune
10.5.1 Altimmune Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Influenza Vaccine
10.5.4 Influenza Vaccine Product Introduction
10.5.5 Altimmune Recent Development
10.6 BionVax
10.6.1 BionVax Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Influenza Vaccine
10.6.4 Influenza Vaccine Product Introduction
10.6.5 BionVax Recent Development
10.7 FluGen
10.7.1 FluGen Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Influenza Vaccine
10.7.4 Influenza Vaccine Product Introduction
10.7.5 FluGen Recent Development
10.8 Folia Biotech
10.8.1 Folia Biotech Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Influenza Vaccine
10.8.4 Influenza Vaccine Product Introduction
10.8.5 Folia Biotech Recent Development
10.9 Genentech
10.9.1 Genentech Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Influenza Vaccine
10.9.4 Influenza Vaccine Product Introduction
10.9.5 Genentech Recent Development
10.10 Green Cross
10.10.1 Green Cross Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Influenza Vaccine
10.10.4 Influenza Vaccine Product Introduction
10.10.5 Green Cross Recent Development
10.11 Medicago
10.12 Moderna Therapeutics
10.13 Novavax
10.14 Shijiazhuang Yiling Pharmaceutical
10.15 SK Chemicals
10.16 UNM Pharma
10.17 Vaccitec
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Influenza Vaccine Sales Channels
11.2.2 Influenza Vaccine Distributors
11.3 Influenza Vaccine Customers
12 Market Forecast
12.1 Global Influenza Vaccine Sales and Revenue Forecast 2019-2025
12.2 Global Influenza Vaccine Sales Forecast by Type
12.3 Global Influenza Vaccine Sales Forecast by Application
12.4 Influenza Vaccine Forecast by Regions
12.4.1 Global Influenza Vaccine Sales Forecast by Regions 2019-2025
12.4.2 Global Influenza Vaccine Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Influenza Vaccine Product Picture
Table Influenza Vaccine Key Market Segments
Table Major Manufacturers Influenza Vaccine Covered in This Report
Table Global Influenza Vaccine Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Influenza Vaccine Sales Market Shar by Type 2014-2025
Figure Fluzone/Vaxigrip Figures
Table Major Manufacturers of Fluzone/Vaxigrip
Figure FluMist Figures
Table Major Manufacturers of FluMist
Figure Fluarix and Flulaval Figures
Table Major Manufacturers of Fluarix and Flulaval
Figure Anflu Figures
Table Major Manufacturers of Anflu
Figure Fluvax/Afluria Figures
Table Major Manufacturers of Fluvax/Afluria
Figure Flucelvax and Fluvirin Figures
Table Major Manufacturers of Flucelvax and Fluvirin
Table Global Influenza Vaccine Market Share by Application 2019-2025 (K Units)
Figure Adults Use Case
Figure Pediatrics Use Case
Figure Senior Citizens Use Case
Figure Influenza Vaccine Report Years Considered
Figure Global Influenza Vaccine Market Size 2014-2025 (Million US$)
Figure Global Influenza Vaccine Sales 2014-2019 (K Units)
Table Global Influenza Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Influenza Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure Global Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure Global Influenza Vaccine Sales Market Share by Regions in 2019
Table Global Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Influenza Vaccine Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Influenza Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Influenza Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Influenza Vaccine Sales Share by Manufacturers in 2019
Table Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Influenza Vaccine Value Share by Manufacturers in 2019
Table Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Influenza Vaccine Price (2014-2019) (USD/Unit)
Table Key Manufacturers Influenza Vaccine Plants/Factories Distribution
Table Key Manufacturers Influenza Vaccine Area Served
Table Date of Key Manufacturers Enter into Influenza Vaccine Market
Table Key Manufacturers Influenza Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Fluzone/Vaxigrip Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global FluMist Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Fluarix and Flulaval Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Anflu Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Fluvax/Afluria Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Flucelvax and Fluvirin Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Influenza Vaccine Sales by Type (2014-2019) (K Units)
Table Global Influenza Vaccine Sales Share by Type (2014-2019)
Figure Global Influenza Vaccine Sales Market Share by Type (2014-2019)
Figure Global Influenza Vaccine Sales Market Share by Type in 2018
Table Global Influenza Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Influenza Vaccine Revenue Share by Type (2014-2019)
Figure Global Influenza Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Influenza Vaccine Revenue Market Share by Type in 2018
Table Influenza Vaccine Price by Type 2014-2019 (USD/Unit)
Table Global Influenza Vaccine Sales by Application (2014-2019) (K Units)
Table Global Influenza Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Influenza Vaccine Market Share by Application (2014-2019)
Figure Global Sales Influenza Vaccine Market Share by Application (2014-2019)
Figure United States Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure United States Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table United States Influenza Vaccine Sales by Company (2014-2019) (K Units)
Table United States Influenza Vaccine Sales Market Share by Company (2014-2019)
Figure United States Influenza Vaccine Sales Market Share by Company in 2019
Table United States Influenza Vaccine Sales by Type (2014-2019) (K Units)
Table United States Influenza Vaccine Sales Market Share by Type (2014-2019)
Figure United States Influenza Vaccine Market Share by Type in 2019
Table United States Influenza Vaccine Sales by Application (2014-2019) (K Units)
Table United States Influenza Vaccine Sales Market Share by Application (2014-2019)
Figure United States Influenza Vaccine Market Share by Application in 2019
Figure European Union Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure European Union Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Influenza Vaccine Sales by Company (2014-2019) (K Units)
Table European Union Influenza Vaccine Sales Market Share by Company (2014-2019)
Figure European Union Influenza Vaccine Sales Market Share by Company in 2019
Table European Union Influenza Vaccine Sales by Type (2014-2019) (K Units)
Table European Union Influenza Vaccine Sales Market Share by Type (2014-2019)
Figure 2018 European Union Influenza Vaccine Market Share by Type
Table European Union Influenza Vaccine Sales by Application (2014-2019) (K Units)
Table European Union Influenza Vaccine Sales Market Share by Application (2014-2019)
Figure 2018 European Union Influenza Vaccine Market Share by Application
Figure China Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure China Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table China Influenza Vaccine Sales by Company (2014-2019) (K Units)
Table China Influenza Vaccine Sales Market Share by Company (2014-2019)
Figure China Influenza Vaccine Sales Market Share by Company in 2019
Table China Influenza Vaccine Sales by Type (2014-2019) (K Units)
Table China Influenza Vaccine Sales Market Share by Type (2014-2019)
Figure China Influenza Vaccine Market Share by Type in 2019
Table China Influenza Vaccine Sales by Application (2014-2019) (K Units)
Table China Influenza Vaccine Sales Market Share by Application (2014-2019)
Figure China Influenza Vaccine Market Share by Application in 2019
Figure Rest of World Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Influenza Vaccine Sales by Company (2014-2019) (K Units)
Table Rest of World Influenza Vaccine Sales Market Share by Company (2014-2019)
Figure Rest of World Influenza Vaccine Sales Market Share by Company in 2019
Table Rest of World Influenza Vaccine Sales by Type (2014-2019) (K Units)
Table Rest of World Influenza Vaccine Sales Market Share by Type (2014-2019)
Figure Rest of World Influenza Vaccine Market Share by Type in 2019
Table Rest of World Influenza Vaccine Sales by Application (2014-2019) (K Units)
Table Rest of World Influenza Vaccine Sales Market Share by Application (2014-2019)
Figure Rest of World Influenza Vaccine Market Share by Application in 2019
Table Rest of World Influenza Vaccine Sales by Countries (2014-2019) (K Units)
Table Rest of World Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure Rest of World Influenza Vaccine Sales Market Share by Countries in 2019
Table Rest of World Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure Rest of World Influenza Vaccine Revenue Market Share by Countries in 2019
Figure Japan Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure India Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Influenza Vaccine Sales Growth Rate (2014-2019)
Table AstraZeneca Influenza Vaccine Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table CSL Company Details
Table CSL Description and Business Overview
Table CSL Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Influenza Vaccine Sales Growth Rate (2014-2019)
Table CSL Influenza Vaccine Sales Market Share in Global Market
Table CSL Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Influenza Vaccine Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Influenza Vaccine Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Influenza Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Influenza Vaccine Sales Market Share in Global Market
Table Sanofi Recent Development
Table Altimmune Company Details
Table Altimmune Description and Business Overview
Table Altimmune Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Altimmune Influenza Vaccine Sales Growth Rate (2014-2019)
Table Altimmune Influenza Vaccine Sales Market Share in Global Market
Table Altimmune Recent Development
Table BionVax Company Details
Table BionVax Description and Business Overview
Table BionVax Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table BionVax Influenza Vaccine Sales Growth Rate (2014-2019)
Table BionVax Influenza Vaccine Sales Market Share in Global Market
Table BionVax Recent Development
Table FluGen Company Details
Table FluGen Description and Business Overview
Table FluGen Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table FluGen Influenza Vaccine Sales Growth Rate (2014-2019)
Table FluGen Influenza Vaccine Sales Market Share in Global Market
Table FluGen Recent Development
Table Folia Biotech Company Details
Table Folia Biotech Description and Business Overview
Table Folia Biotech Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Folia Biotech Influenza Vaccine Sales Growth Rate (2014-2019)
Table Folia Biotech Influenza Vaccine Sales Market Share in Global Market
Table Folia Biotech Recent Development
Table Genentech Company Details
Table Genentech Description and Business Overview
Table Genentech Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech Influenza Vaccine Sales Growth Rate (2014-2019)
Table Genentech Influenza Vaccine Sales Market Share in Global Market
Table Genentech Recent Development
Table Green Cross Company Details
Table Green Cross Description and Business Overview
Table Green Cross Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Green Cross Influenza Vaccine Sales Growth Rate (2014-2019)
Table Green Cross Influenza Vaccine Sales Market Share in Global Market
Table Green Cross Recent Development
Table Medicago Company Details
Table Moderna Therapeutics Company Details
Table Novavax Company Details
Table Shijiazhuang Yiling Pharmaceutical Company Details
Table SK Chemicals Company Details
Table UNM Pharma Company Details
Table Vaccitec Company Details
Figure Influenza Vaccine Value Chain
Table Influenza Vaccine Distributors List
Table Influenza Vaccine Customers List
Table Global Influenza Vaccine Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure Global Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Influenza Vaccine Sales Forecast by Type 2019-2025 (K Units)
Figure Global Influenza Vaccine Sales Forecast by Type 2019-2025 (K Units)
Figure Global Influenza Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Influenza Vaccine Sales Forecast by Application 2019-2025 (K Units)
Figure Global Influenza Vaccine Sales Forecast by Application 2019-2025 (K Units)
Figure Global Influenza Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Influenza Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Influenza Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure United States Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure United States Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure European Union Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure European Union Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure China Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure China Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Japan Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure Japan Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Korea Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure Korea Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure India Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure India Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Influenza Vaccine Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
Folia Biotech
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitec
- PRICE
-
$3280$6560